跳至主要内容
临床试验/EUCTR2009-011360-10-ES
EUCTR2009-011360-10-ES进行中(未招募)1 期

Efectos de ivabradina en pacientes con arteriopatía coronaria estable sin insuficiencia cardíaca clínica. Estudio multicéntrico, internacional, aleatorizado, doble ciego, controlado con placeboStudy assessInG the morbi-mortality beNefits of the If inhibitor ivabradine in patients with coronary arterY disease (SIGNIFY)Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre study.Study assessInG the morbi-mortality beNefits of the If inhibitor ivabradine in patients with coronary arterY disease (SIGNIFY) - SIGNIFY

Institut de Recherches Internationales Servier0 个研究点目标入组 19,102 人开始时间: 2009年8月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
19,102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Pacientes con 55 años o mayores
  • - Hombres y mujer,
  • - Pacientes con arteriopatia coronaria sin insuficiencia cardiaca clínica,
  • - Ritmo sinusal y frecuencia cardiaca en reposo igual o mayor a 70 lpm.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Condicion cardiovascular estable,
  • - Contraindicación de la administración de ivabradina o en tratamiento con ivabradina comercializada.

研究者

相似试验

已完成
2 期
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial function;An international, multicentre, randomised, double-blind, placebo-controlled study over 12 weeks.impaired endothelial function10003216
NL-OMON40596Servier R&D Benelux200
进行中(未招募)
不适用
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial functioCardiovascular disease
EUCTR2012-000215-89-NLInstitut de Recherches Internationales Servier340
进行中(未招募)
不适用
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial functioCardiovascular diseaseMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849
EUCTR2012-000215-89-ITInstitut de Recherches Internationales Servier340
进行中(未招募)
1 期
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial functioCardiovascular disease
EUCTR2012-000215-89-GBInstitut de Recherches Internationales Servier4
进行中(未招募)
不适用
A trial to investigate whether Ivabradine can reduce the amount of subtle heart damage that can be suffered during stent procedures.
EUCTR2015-003260-37-GBiverpool Heart and Chest Hospital
Efectos de ivabradina en pacientes con arteriopatía... | 临床试验